Shweta Khandelwal1, Laura Kelly2, Richa Malik3, Dorairaj Prabhakaran4, Srinath Reddy3. 1. Centre for Chronic Disease Control, New Delhi, India ; Public Health Foundation of India, New Delhi, India. 2. Rollins School of Public Health, Emory University, Atlanta. 3. Public Health Foundation of India, New Delhi, India. 4. Centre for Chronic Disease Control, New Delhi, India.
Abstract
Poly unsaturated fatty acids (PUFAs) have usually been associated with beneficial health effects on early life and later life disease such as cardiovascular diseases (CVD). Emerging evidence, however, suggests that PUFA species (n-3, n-6) have differential health effects. N-6 PUFAs, in particular, have sparked a scientific debate regarding their role in human physiological processes. Current dietary recommendations for n-6 fatty acids have been based on animal studies, insufficient epidemiological evidence and mixed PUFA interventions, therefore, require reconsideration. This review has analyzed human epidemiological and interventional studies, published in the last five years, focusing on n-6 fatty acids' impact on CVD outcomes (CVD events, blood lipids, blood pressure, inflammation, oxidative stress/atherosclerosis). The evidence is mixed, with differential effects within the n-6 fatty acid series. These outcomes are also dependent on ethnicity and background health status. Further, data from developing countries are sparse, thus, well designed intervention trials and population based studies in developing country settings on specific n-6 fatty acid intake and health effects are desired.
Poly unsaturated fatty acids (n class="Chemical">PUFAs) have usually been associated with beneficial health effects on early life and later life disease such as cardiovascular diseases (CVD). Emerging evidence, however, suggests that PUFA species (n-3, n-6) have differential health effects. N-6PUFAs, in particular, have sparked a scientific debate regarding their role in human physiological processes. Current dietary recommendations for n-6 fatty acids have been based on animal studies, insufficient epidemiological evidence and mixed PUFA interventions, therefore, require reconsideration. This review has analyzed human epidemiological and interventional studies, published in the last five years, focusing on n-6 fatty acids' impact on CVD outcomes (CVD events, blood lipids, blood pressure, inflammation, oxidative stress/atherosclerosis). The evidence is mixed, with differential effects within the n-6 fatty acid series. These outcomes are also dependent on ethnicity and background health status. Further, data from developing countries are sparse, thus, well designed intervention trials and population based studies in developing country settings on specific n-6 fatty acid intake and health effects are desired.
Authors: L H Kushi; R A Lew; F J Stare; C R Ellison; M el Lozy; G Bourke; L Daly; I Graham; N Hickey; R Mulcahy Journal: N Engl J Med Date: 1985-03-28 Impact factor: 91.245
Authors: P C Calder; A D Dangour; C Diekman; A Eilander; B Koletzko; G W Meijer; D Mozaffarian; H Niinikoski; S J M Osendarp; P Pietinen; J Schuit; R Uauy Journal: Eur J Clin Nutr Date: 2010-12 Impact factor: 4.016
Authors: Y J Schreuder; B A Hutten; M van Eijsden; E H Jansen; M N Vissers; M T Twickler; T G M Vrijkotte Journal: Eur J Clin Nutr Date: 2011-01-19 Impact factor: 4.016
Authors: Zhi-Hong Yang; Kimball Nill; Yuki Takechi-Haraya; Martin P Playford; David Nguyen; Zu-Xi Yu; Milton Pryor; Jingrong Tang; Krishna Vamsi Rojulpote; Nehal N Mehta; Han Wen; Alan T Remaley Journal: Int J Mol Sci Date: 2022-07-29 Impact factor: 6.208
Authors: Marialaura Simonetto; Marco Infante; Ralph L Sacco; Tatjana Rundek; David Della-Morte Journal: Nutrients Date: 2019-09-23 Impact factor: 5.717